DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,053,000 | -19.5% | 214,845 | 0.0% | 0.05% | -13.2% |
| Q2 2019 | $1,308,000 | +4.8% | 214,845 | 0.0% | 0.05% | +3.9% |
| Q1 2019 | $1,248,000 | -81.7% | 214,845 | -57.5% | 0.05% | -82.5% |
| Q4 2018 | $6,807,000 | -20.1% | 505,701 | +15.2% | 0.29% | -5.8% |
| Q3 2018 | $8,521,000 | -24.1% | 439,001 | 0.0% | 0.31% | -27.5% |
| Q2 2018 | $11,221,000 | +26.8% | 439,001 | 0.0% | 0.43% | +23.8% |
| Q1 2018 | $8,846,000 | -31.2% | 439,001 | -31.5% | 0.34% | -30.6% |
| Q4 2017 | $12,855,000 | +34.4% | 640,492 | +38.7% | 0.50% | +45.0% |
| Q3 2017 | $9,562,000 | +39.9% | 461,712 | 0.0% | 0.34% | +35.2% |
| Q2 2017 | $6,833,000 | +229.0% | 461,712 | +254.6% | 0.25% | +212.3% |
| Q1 2017 | $2,077,000 | +26.6% | 130,223 | 0.0% | 0.08% | +15.7% |
| Q4 2016 | $1,641,000 | -32.8% | 130,223 | +49.4% | 0.07% | -25.5% |
| Q3 2016 | $2,441,000 | – | 87,163 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |